Changes in expression of NLRP3 inflamasome and IL-1β in the development of oxazolone-induced colitis in rats and on the background of administration of simvastatin and interleukin-1β receptor antagonist
DOI:
https://doi.org/10.14739/2310-1237.2021.1.228928Keywords:
colitis, NLRP3 protein, inflammasomes, IL-1βAbstract
The aim. To study the expression of mRNA of the NLRP3 inflammasome and proinflammatory cytokine IL-1β in the inflamed colon of rats with experimental oxazolone-induced colitis and against the background of the introduction of simvastatin and antagonist of interleukin-1 receptors.
Materials and methods. Experiments were carried out on male Wistar rats aged 8 months (body mass 120–150 g). Tissue samples were obtained from rats with experimental oxazolone-induced colitis (n = 20), rats with oxazolone-induced colitis treated with simvastatin (n = 20); rats with oxazolone-induced colitis treated with interleukin-1 receptor antagonist (n = 20) and control animals (n = 10). Clinical signs of colitis were evaluated by the clinical index of disease activity on the following parameters: weight loss, stool consistency and animal behavior. For macroscopic assessment of the development of colitis areas of inflammation and ulceration were investigated. For histological evaluation of lesions, sections of the intestine were stained with hematoxylin and eosin and cellular inflammatory infiltrates, epithelial hyperplasia, ulceration and loss of intestinal glands were studied. IL-1β and NLRP3 inflammasome mRNA expression was analyzed by real-time reverse transcriptase-polymerase chain reaction.
Results. Animals treated with oxazolone rapidly developed colitis marked by weight loss and diarrhea peaking by day 2 after oxazolone administration and leading to death of 40 % of the rats by day 4. The histological observation showed inflammatory cell infiltration, including polymorphonuclear leukocytes and multiple erosive lesions in the large intestine. We determined that the expression level of the proinflammatory cytokine IL-1β is increased in colon samples of rats with oxazolone-induced colitis. IL-1β expression is increased 3.5‐fold in inflamed colon compared to uninflamed tissue. Administration of simvastatin and an interleukin-1 receptor antagonist to rats with oxazolone-induced colitis resulted in a 30 % and 2-fold decrease expression of IL-1β in colon samples. In addition, we examined NLRP3 expression in these tissues. RT‐PCR analysis demonstrates a 71‐fold increased expression of NLRP3 mRNA expression in colon samples tested. Administration of simvastatin and an interleukin-1 receptor antagonist to rats with oxazolone-induced colitis resulted in a 2.5- to 3.0-fold decrease expression of NLRP3 mRNA in colon samples.
Conclusions. IL-1β and NLRP3 mRNA expression levels were elevated in the inflamed colon of rats with experimental oxazolone-induced colitis. Administration of simvastatin and an interleukin-1 receptor antagonist against the background of colitis caused a decrease in the expression levels of IL-1β and NLRP3 mRNA in the tissues of the intestine. Detection of abnormal expression of IL-1β and NLRP3 mRNA could provide insights into pathogenesis of Crohn's disease, and may help to identify future potential targets for therapeutic strategies in people with inflammatory bowel disease.
References
Tourkochristou, E., Aggeletopoulou, I., Konstantakis, C., & Triantos, C. (2019). Role of NLRP3 inflammasome in inflammatory bowel diseases. World journal of gastroenterology, 25(33), 4796-4804. https://doi.org/10.3748/wjg.v25.i33.4796
Randhawa, P. K., Singh, K., Singh, N., & Jaggi, A. S. (2014). A review on chemical-induced inflammatory bowel disease models in rodents. The Korean journal of physiology & pharmacology, 18(4), 279-288. https://doi.org/10.4196/kjpp.2014.18.4.279
Hanaei, S., Sadr, M., Rezaei, A., Shahkarami, S., Ebrahimi Daryani, N., Bidoki, A. Z., & Rezaei, N. (2018). Association of NLRP3 single nucleotide polymorphisms with ulcerative colitis: A case-control study. Clinics and research in hepatology and gastroenterology, 42(3), 269-275. https://doi.org/10.1016/j.clinre.2017.09.003
Jain, M. K., Ridker, P. M. (2005). Anti-inflammatory effects of statins: clinical evidence and basic mechanisms. Nature reviews. Drug discovery, 4(12), 977-987. https://doi.org/10.1038/nrd1901
Suprun, O., Gromov, L., Belenichev, I., & Suprun, E. (2014). IL-1Ra stabilises the thiol–disulfide system in the brain tissues of rats with experimental diabetes and cerebral ischemia. European Neuropsychopharmacology, 24(Suppl 2), S236-S237. https://doi.org/10.1016/s0924-977x(14)70368-2
Shchokіna, K. G. (2011). Orhanotropni efekty rekombinantnoho antahonista retseptoriv interleikinu-1 (eksperymentalne doslidzhennia) [Organotropic effects of recombinant receptor antagonist of interleukin-1 (experimental researh) (Doctoral dissertation)]. National Pharmaceutical University. [in Ukrainian].
Wirtz, S., Neufert, C., Weigmann, B., & Neurath, M. F. (2007). Chemically induced mouse models of intestinal inflammation. Nature protocols, 2(3), 541-546. https://doi.org/10.1038/nprot.2007.41
Wang, Y., Tong, J., Chang, B., Wang, B., Zhang, D., & Wang, B. (2014). Effects of alcohol on intestinal epithelial barrier permeability and expression of tight junction-associated proteins. Molecular medicine reports, 9(6), 2352-2356. https://doi.org/10.3892/mmr.2014.2126
Belenichev, I. F., Ishchenko, A. M., Simbirtsev, A. S., Burlaka, B. S. Bukhtiyarova, N. V. & Suprun, E. V. (2021). Pharmacological correction of thiol-disulphide imbalance in the rat brain by intranasal form of Il-1b antagonist in a model of chronic cerebral ischemia. Neurochemical Journal, 15(1), 30-36.
Seiler, C., Sharpe, A., Barrett, J. C., Harrington, E. A., Jones, E. V., & Marshall, G. B. (2016). Nucleic acid extraction from formalin-fixed paraffin-embedded cancer cell line samples: a trade off between quantity and quality?. BMC clinical pathology, 16, 17. https://doi.org/10.1186/s12907-016-0039-3
Khalil, P. N., Weiler, V., Nelson, P. J., Khalil, M. N., & Moosmann, S. (2007). Nonmyeloablative stem cell therapy enhances microcirculation and tissue regeneration in murine inflammatory bowel disease. Gastroenterology, 132(3), 944-954. https://doi.org/10.1053/j.gastro.2006.12.029
Morris, G. P., Beck, P. L., Herridge, M. S., Depew, W. T., Szewczuk, M. R., & Wallace, J. L. (1989). Hapten-induced model of chronic inflammation and ulceration in the rat colon. Gastroenterology, 96(3), 795-803.
Bustin, S. A. (2002). Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems. Journal of molecular endocrinology, 29(1), 23-39. https://doi.org/10.1677/jme.0.0290023
Li, J., Moran, T., Swanson, E., Julian, C., Harris, J., Bonen, D. K., Hedl, M., Nicolae, D. L., Abraham, C., & Cho, J. H. (2004). Regulation of IL-8 and IL-1beta expression in Crohn's disease associated NOD2/CARD15 mutations. Human molecular genetics, 13(16), 1715-1725. https://doi.org/10.1093/hmg/ddh182
Bersudsky, M., Luski, L., Fishman, D., White, R. M., Ziv-Sokolovskaya, N., Dotan, S., Rider, P., Kaplanov, I., Aychek, T., Dinarello, C. A., Apte, R. N., & Voronov, E. (2014). Non-redundant properties of IL-1α and IL-1β during acute colon inflammation in mice. Gut, 63(4), 598-609. https://doi.org/10.1136/gutjnl-2012-303329
Latz, E., Xiao, T. S., & Stutz, A. (2013). Activation and regulation of the inflammasomes. Nature reviews. Immunology, 13(6), 397-411. https://doi.org/10.1038/nri3452
Itani, S., Watanabe, T., Nadatani, Y., Sugimura, N., Shimada, S., Takeda, S., Otani, K., Hosomi, S., Nagami, Y., Tanaka, F., Kamata, N., Yamagami, H., Tanigawa, T., Shiba, M., Tominaga, K., Fujiwara, Y., & Arakawa, T. (2016). NLRP3 inflammasome has a protective effect against oxazolone-induced colitis: a possible role in ulcerative colitis. Scientific reports, 6, 39075. https://doi.org/10.1038/srep39075
Petryna, V. O. (2017). Efektyvnist terapii nespetsyfichnoho vyrazkovoho kolitu z urakhuvanniam sposobu vvedennia likarskykh zasobiv [The effectiveness of ulcerative colitis treatment depending on the route of medical drug usage]. Zaporozhye medical journal, 19(4), 446-450. [in Ukrainian]. https://doi.org/10.14739/2310-1210.2017.4.105030
Maeda, S., Ohno, K., Nakamura, K., Uchida, K., Nakashima, K., Fukushima, K., Tsukamoto, A., Goto-Koshino, Y., Fujino, Y., & Tsujimoto, H. (2012). Mucosal imbalance of interleukin-1β and interleukin-1 receptor antagonist in canine inflammatory bowel disease. Veterinary journal, 194(1), 66-70. https://doi.org/10.1016/j.tvjl.2012.02.026
Ey, B., Eyking, A., Klepak, M., Salzman, N. H., Göthert, J. R., Rünzi, M., Schmid, K. W., Gerken, G., Podolsky, D. K., & Cario, E. (2013). Loss of TLR2 worsens spontaneous colitis in MDR1A deficiency through commensally induced pyroptosis. Journal of immunology, 190(11), 5676-5688. https://doi.org/10.4049/jimmunol.1201592
Rea, W. E., Durrant, D. C., & Boldy, D. A. (2002). Ulcerative colitis after statin treatment. Postgraduate medical journal, 78(919), 286-287. https://doi.org/10.1136/pmj.78.919.286
Maheshwari, R. A., Balaraman, R., Sailor, G. U., & Sen, D. B. (2015). Protective effect of simvastatin and rosuvastatin on trinitrobenzene sulfonic acid-induced colitis in rats. Indian journal of pharmacology, 47(1), 17-21. https://doi.org/10.4103/0253-7613.150311
Downloads
Published
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (SeeThe Effect of Open Access).
